Clinic Software← All companies
Relief Cardiovascular
StageSeries A
Raised$12M - $13.5M
Employees13
LocationCosta Mesa, CA
About
Relief Cardiovascular, an inQB8 Medical Technologies portfolio company, is creating a novel smart implant to decongest heart failure patients. The Relief System is the world’s first transcatheter implant to both monitor and modulate renal vein pressures, offering a novel solution for managing fluid in heart failure patients – particularly for the millions of heart failure patients with diuretic resistance.
Product
- Value proposition
- Transcatheter preload modulating implant system with autonomous hemodynamic monitoring to reduce congestion and improve perfusion in heart failure patients.
- Target customers
- cardiovascular clinicians, hospitals, reference centers for heart failure management
- Regulatory
- Clinical investigation started in September 2025 (OUS); cautions: not available in USA for clinical trials or commercialization
Founders
- Alex Cooper (CEO)
- Dr. Arshad Quadri (inQB8 co-founder)
- J. Brent Ratz (inQB8 co-founder)
Categories
medical devicescardiovascular
Products
Relief System (transcatheter preload modulating implant)
Key features
autonomous hemodynamic monitoringmodulation of venous returnworld’s first transcatheter preload modulating implant
Technologies
transcatheter implantimplantable devicehemodynamic monitoringvolume management
Target conditions
congestive heart failureheart failure with volume overload
Care settings
hospitalclinicoperating roomcatheterization lab
Partnerships
Broadview VenturesAdvent Life SciencesGood Growth CapitalHeartwork Capital
Awards
Jon DeHaan Foundation Award for Innovation in Cardiology (Cardiovascular Research Foundation’s TCT Conference, 2025)
Investors
Advent Life SciencesBroadview VenturesPacific Health InvestmentHeartwork CapitalGood Growth CapitalMinogue ConsultingUndisclosed multinational strategic
News
- Relief Cardiovascular | LinkedIn · 2025-02-08T00:00:00.000Z
- Relief Cardiovascular Announces $12M Series A Financing to Advance First-in-Human Study of the Relief System · 2025-01-08T14:00:00.000Z
- Relief Cardiovascular has positive smart heart implant data · 2026-03-04T12:51:48.000Z
- RELIEF CARDIOVASCULAR REPORTS POSITIVE FIRST-IN-HUMAN DATA FOR DEVICE-BASED DECONGESTION THERAPY IN HEART FAILURE PATIENTS · 2026-03-03T17:00:00.000Z
- Relief Cardiovascular Announces First-in-Human Procedures with... · 2025-09-30T00:00:00.000Z
- Relief Cardiovascular’s Transcatheter Smart Implant for Congestion in Heart Failure Used in FIH Procedures - Cardiac Interventions Today · 2025-10-06T19:05:25.000Z
